Addie M. Peretz
Research Subjects
Addie M. Peretz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Pikula
Toronto Western Hospital (A.P.), University of Toronto, ON, Canada
1 shared publication - Barbara Mostacci
Istituto delle Scienze Neurologiche di Bologna, Italy, Full member of the ERN EpiCARE
1 shared publication - Bharati M. Sanjanwala
Stanford University School of Medicine
1 shared publication - Esther Bui
University of Toronto
1 shared publication - Ginette Moores
Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada
1 shared publication - Hayley Faye Thornton
Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada
1 shared publication
Latest Publications
- 1 December 2026
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 16 (6) , e200678
Menopause and Neurology
Purpose of ReviewMenopause is a neurobiological transition with important implications for neurologic care. This review summarizes the physiology and hormonal changes of spontaneous menopause and i...
- 1 December 2026
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 16 (6) , e200678
Menopause and Neurology
Purpose of ReviewMenopause is a neurobiological transition with important implications for neurologic care. This review summarizes the physiology and hormonal changes of spontaneous menopause and i...
- Open Access
- 30 March 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Comparing detailed phenotypic characteristics and treatment outcome among menstrual-related and non-menstrual-related migraine
Background: Menstrual-related migraine (MRM) is a subtype of migraine that significantly impacts women. Despite its high prevalence, MRM remains under-researched compared to other migraine types. This study investigates the phenotypic characteristics and treatment outcomes of MRM compared to non-menstrual migraine (non-MRM). Methods: This cross-sectional study included women aged 18 years or older with a diagnosis of migraine and an established menstruation pattern. Informed consent was properly obtained from all participants from the Stanford Headache Clinic and surrounding community between 2014 and 2024 prior to participation in the study. Data were collected from self-reported surveys, including demographic information, headache characteristics, physical and mental health status, and treatment outcomes from the Stanford Headache Clinic and surrounding community. Participants were then categorized into MRM and non-MRM groups. An exploratory analysis was performed to investigate phenotypic features, treatment outcomes, and brain volume through magnetic resonance imaging (MRI) study for each group. Statistical analyses included descriptive statistics, analysis of covariance (ANCOVA), and logistic regression. Results: A total of 84 subjects were included, with 38 in the MRM group and 46 in the non-MRM group. The mean age of participants was 34 (SD = 9) years. The MRM group (mean age 38 ± 9) showed significantly higher prevalences of recent change in migraine frequency, migraine attacks occurring in the same site, prodromal signs, speech aura, nausea, and vomiting associated with migraine, and a higher prevalence of reported family history of headache as compared with the non-MRM group (mean age 31 ± 10) (p < 0.05). MRM group also showed significantly higher rate of migraine improvement following the use of triptans and the overall acute and preventive medications (p < 0.05). No significant differences were found in brain volumes between the groups (p > 0.05). Conclusion: The MRM group was associated with significantly more bothersome symptoms associated with migraine, higher family history of headache, and more favorable response to overall acute medication especially triptan as compared with the non-MRM group.
- 30 March 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessComparing detailed phenotypic characteristics and treatment outcome among menstrual-related and non-menstrual-related migraine
Background: Menstrual-related migraine (MRM) is a subtype of migraine that significantly impacts women. Despite its high prevalence, MRM remains under-researched compared to other migraine types. This study investigates the phenotypic characteristics and treatment outcomes of MRM compared to non-menstrual migraine (non-MRM). Methods: This cross-sectional study included women aged 18 years or older with a diagnosis of migraine and an established menstruation pattern. Informed consent was properly obtained from all participants from the Stanford Headache Clinic and surrounding community between 2014 and 2024 prior to participation in the study. Data were collected from self-reported surveys, including demographic information, headache characteristics, physical and mental health status, and treatment outcomes from the Stanford Headache Clinic and surrounding community. Participants were then categorized into MRM and non-MRM groups. An exploratory analysis was performed to investigate phenotypic features, treatment outcomes, and brain volume through magnetic resonance imaging (MRI) study for each group. Statistical analyses included descriptive statistics, analysis of covariance (ANCOVA), and logistic regression. Results: A total of 84 subjects were included, with 38 in the MRM group and 46 in the non-MRM group. The mean age of participants was 34 (SD = 9) years. The MRM group (mean age 38 ± 9) showed significantly higher prevalences of recent change in migraine frequency, migraine attacks occurring in the same site, prodromal signs, speech aura, nausea, and vomiting associated with migraine, and a higher prevalence of reported family history of headache as compared with the non-MRM group (mean age 31 ± 10) (p < 0.05). MRM group also showed significantly higher rate of migraine improvement following the use of triptans and the overall acute and preventive medications (p < 0.05). No significant differences were found in brain volumes between the groups (p > 0.05). Conclusion: The MRM group was associated with significantly more bothersome symptoms associated with migraine, higher family history of headache, and more favorable response to overall acute medication especially triptan as compared with the non-MRM group.